News

Join our newsletter

Sign up to read about our latest portfolio updates, fund news and industry insights.

Thanks for subscribing to our newsletter
Oops! Something went wrong

Latest news

Portfolio
//
Coreshell Technologies
//
March 14, 2024

This battery startup says it's found a way to make cheap LFP batteries without sacrificing range | TechCrunch

Coreshell, a battery materials startup, revealed a breakthrough this week that could lower the cost of lithium-ion batteries while reducing reliance on China.

Portfolio
//
Coreshell Technologies
//
March 11, 2024

Ferroglobe & Coreshell Sign a Memorandum of Understanding to Deliver World’s First Battery-Grade Metallurgical Silicon for Electric Vehicles

Ferroglobe & Coreshell Sign a Memorandum of Understanding to Deliver World’s First Battery-Grade Metallurgical Silicon for Electric Vehicles...

Portfolio
//
Agriloops
//
February 13, 2024

La start-upAgriloops lève 13M€ pour produire des gambas durables en France

Ne plus importer des dizaines de milliers de tonnes de gambas de l'autre bout du monde et en produire en Bretagne grâce à une technologie inédite, c'est le rêve des fondateurs d'Agriloops. Et, avec leur nouvelle levée de 13millions, ce rêve pourrait un jour devenir réalité.

Portfolio
//
GenEdit
//
January 23, 2024

Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

The next wave of gene editing advances will likely center not only on efficacy but on the diversity of where the therapies can be delivered, and Genentech is signing a new deal to keep up with the | Roche is the latest large pharma to buy into GenEdit's nanoparticle delivery tech for gene editing therapies, paying $15 million upfront. The biotech previously added Eli Lilly as an investor and inked a partnership with Sarepta.

Portfolio
//
Unnatural Products
//
January 23, 2024

Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’

Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co. | Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co. has pushed further into the space by penning a $220 million biobucks deal with Unnatural Products.

Features
//
//
January 15, 2024

Marianne Abib Pech, à fonds pour le durable

Après une jolie carrière financière, Marianne Abib Pech a quitté le confort du rond-de-cuir pour se mettre à son compte et tenter de réorienter les investisseurs vers une industrie bien réelle, qui prenne en compte les enjeux environnementaux du XXI e siècle.

Portfolio
//
Resynergi
//
January 10, 2024

Resynergi Raises $6.4M in Series B Funding Co-led By Transitions First and Lummus Technology To Scale Plastic Recycling Technology

Resynergi, a pioneering leader in plastic recycling technology, announced today it has raised $6.4M in series B funding co-led by Transitions First and Lummus Technology

Portfolio
//
Resynergi
//
January 10, 2024

Lummus Strengthens Position in Circular Economy

Lummus Strengthens Position in Circular Economy - Investment in Resynergi will scale groundbreaking microwave pyrolysis...